Treatment
Metoprolol clinical trials
We’re tracking 13 recruiting studies that include Metoprolol, each written for real people, not researchers, below.
Recruiting studies
- NCT06879769Recruiting
Better heart CT scan preparation study
This study looks at how to improve the preparation and imaging techniques for heart CT scans. It may help make the scan more comfortable and accurate for people who already have a heart CT scheduled.
Stockholm, HuddingeAges 18 years+ - NCT05631730RecruitingPhase 3
Flecainide plus metoprolol vs metoprolol alone for rhythm control
This trial studies whether adding flecainide to metoprolol can better reduce dangerous heart rhythm problems in people with mitral valve prolapse. It also checks safety and side effects compared with metoprolol alone.
OsloAges 18 years+ - NCT07490067RecruitingPhase 4
Metoprolol for heart failure: genes and drug response
This trial tests how the drug metoprolol works in people with heart failure and reduced pumping function. It looks at whether your genetic makeup affects how the drug is processed and how well it helps your heart.
Ann Arbor, MichiganAges 18 years+ - NCT03519906Recruiting
Bariatric surgery study measuring how metoprolol is absorbed
This study looks at how metoprolol (a blood-pressure medicine) gets absorbed in the body before and after bariatric weight-loss surgery. If you’re preparing for gastric bypass or sleeve surgery, this may help researchers understand dosing and medicine absorption changes after surgery.
TrondheimAges 18–70 - NCT04914234RecruitingPhase 4
Atenolol vs metoprolol for low blood pressure during nasal surgery
This trial compares two commonly used blood-pressure medicines—atenolol and metoprolol—to see which one works best for keeping blood pressure safely low during nasal surgeries. It may help patients have more stable anesthesia while reducing side effects from blood pressure changes.
Damanhūr, El-BeheiraAges 21–50 - NCT05066633RecruitingPhase 3
Metoprolol added to standard care to prevent heart muscle damage
This trial tests whether adding metoprolol (a beta-blocker) to usual care can prevent or slow cardiomyopathy (heart muscle weakness) in people with Duchenne muscular dystrophy (DMD). It also checks for safety, especially effects on heart rate and rhythm.
Gdansk, Pomeranian VoivodeshipAges 8–17 - NCT06964464RecruitingPhase 4
Comparing two heart failure medications in ICD patients
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
Scottsdale, ArizonaAges 18 years+ - NCT06569212RecruitingPhase 4
Beta-blocker to reduce heart damage after brain bleed
This trial tests whether a common beta-blocker (metoprolol) can protect the heart from injury and reduce inflammation after a bleed in the brain (subarachnoid hemorrhage). It may help patients recover better after this type of stroke.
Portland, MaineAges 18 years+ - NCT05931276RecruitingPhase 3
Beta blocker choice may improve heart outcomes on dialysis
This phase 3 study tests whether a specific beta blocker selection on hemodialysis can improve cardiovascular outcomes. It focuses on certain beta blockers commonly used through the VA pharmacy and compares them in a randomized way.
Long Beach, CaliforniaAges 18 years+ - NCT06864234RecruitingPhase 4
Beta-blockers for chest pain without blocked arteries
This trial tests if beta-blocker medication improves blood flow and reduces resistance in the tiny blood vessels of the heart in people who have chest pain but no major blockages in their arteries.
Aalst, FlandersAges 18 years+ - NCT06967194Recruiting
Early beta blocker use after heart attack with fast heart rate or low blood pressure
This trial is testing whether giving a beta-blocker medication (metoprolol) early after a heart attack can help people who have a fast heart rate or low blood pressure but no signs of organ failure. The goal is to see if this treatment improves recovery.
Tel AvivAges 18 years+ - NCT07568574Enrolling by invitation
Medical Study of Performance-Enhancing Substances in Elite Athletes
This study looks at how medically supervised performance-enhancing substances affect elite athletes' health and quality of life. Participants must be retired from professional sports and willing to undergo careful medical monitoring throughout the trial.
Abu DhabiAges 18 years+ - NCT07268170Enrolling by invitationPhase 2/Phase 3
Heart rate control before heart CT scan
This trial tests two medicines to lower heart rate before a cardiac CT scan in adults who need the scan. It is for people whose heart rate is naturally a bit fast (over 65 beats per minute) but not too fast (under 100 bpm).
HerningAges 30–80
What Metoprolol is being studied for
Conditions with recruiting Metoprolol studies.
Common questions
- Are there clinical trials studying Metoprolol?
- Yes. Clin2 currently lists 13 recruiting studies that include Metoprolol, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Metoprolol trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Metoprolol an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Metoprolol or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.